Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Microorganisms including viruses and bacteria" is a broad, non-canonical category encompassing diverse infectious agents that can cause disease in humans and other hosts. They are frequent targets of therapeutic intervention through broad- or narrow-spectrum antibiotics, antivirals, and other anti-infective agents. However, because this term refers to groups rather than specific molecules or biological entities, it cannot be classified as a single therapeutic target. Modern drug development increasingly emphasizes narrow-spectrum or targeted approaches (e.g., species- or strain-specific) to avoid collateral damage to the beneficial microbiome and limit resistance[1][2]. Additionally, microbial biofilms and metabolic pathways can be targeted for more efficient and selective therapies, but each approach still focuses on specific, well-defined molecular targets within individual microbes[4][1]. This entry is too broad for molecular target databases, where each entry should ideally represent a unique, well-defined biological molecule or structure.
Inhibition of cell wall or membrane synthesis (antibiotics targeting bacteria); Inhibition of metabolic enzymes/proteins (e.g., bacterial or viral enzymes targeted by drugs); Inhibition of nucleic acid replication (many antivirals/bactericidals); Disruption of biofilm matrix or signaling (biofilm-targeting therapies); Immune modulation or enhancement (some biologics, vaccines).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microorganism (including virus and bacterium).